Comparison between venlafaxine & citaloperam in menopausal women with sleep disorders

Comparison between venlafaxine & citaloperam in menopausal women with sleep disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201210152576N6

Enrollment

Registered

2012-10-27

Start date

2012-11-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause. Menopausal symptoms

Interventions

Intervention 1: Placebo:Tablet placebo/ 1 tablet at bed time for 8 weeks. Intervention 2: Intervention : Tablet Citaloperam/1 tablet at bed time 20mg/day for 8 weeks . Intervention 3: Control: Tablet

Placebo

Treatment - Drugs

Placebo:Tablet placebo/ 1 tablet at bed time for 8 weeks

Intervention : Tablet Citaloperam/1 tablet at bed time 20mg/day for 8 weeks .

Control: Tablet Venlafaxine 75mg/day for 8 weeks at bed time.

Eligibility

Sex/Gender

Female

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: menopausal women with sleep disorders. Exclusion criteria: women who use benzodiazepines or they have history of depression.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sleep disorders. Timepoint: Before intervention, 8 and 12 weeks after intervention. Method of measurement: Pittsburgh's questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavari@yahoo.com+98 21 8889 7764

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026